New combo shows promise for tough lung cancer
NCT ID NCT05312840
First seen Jun 02, 2026 · Last updated Jun 11, 2026 · Updated 4 times
Summary
This study tested a combination of two chemotherapy drugs (platinum and gemcitabine) plus an immunotherapy drug (sintilimab) in 20 people with advanced squamous non-small cell lung cancer. The goal was to see if this treatment could shrink tumors and help patients live longer without their cancer growing. The study looked at how well the treatment worked and what side effects occurred.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Quzhou people's Hospital
Quzhou, Zhejiang, China
Conditions
Explore the condition pages connected to this study.
Conditions inferred from the trial description
These were inferred from the trial's summary, not listed by the trial registrant.